iodine has been researched along with Carcinoma, Non-Small Cell Lung in 16 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether iodine quantification extracted from enhanced dual energy-computed tomography (DE-CT) is useful for distinguishing lung squamous cell carcinoma from adenocarcinoma and to evaluate whether a single scan evaluated during the venous phase (VP) can be substituted for scans evaluated during other phases." | 3.96 | A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase. ( Chen, J; Gong, L; Jiang, F; Liu, Y; Yuan, A; Zhang, Z; Zhao, B; Zou, H; Zuo, M, 2020) |
| "One hundred and six untreated lung cancer patients who underwent DECT before biopsy or surgery were prospectively enrolled." | 1.51 | Clinical utility of quantitative dual-energy CT iodine maps and CT morphological features in distinguishing small-cell from non-small-cell lung cancer. ( Du, Q; Ge, Y; Jiang, J; Jin, Z; Song, L; Song, W; Sui, X; Wang, X; Wang, Z; Xu, X; Xu, Y; Zhong, W, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 9 (56.25) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, L | 1 |
| Liu, L | 1 |
| Zhao, H | 1 |
| Bao, J | 1 |
| Dou, Y | 1 |
| Yang, Z | 1 |
| Lin, Y | 1 |
| Sun, Z | 1 |
| Meng, L | 1 |
| Yan, L | 1 |
| Liu, A | 1 |
| Martin, SS | 1 |
| Muscogiuri, E | 1 |
| Burchett, PF | 1 |
| van Assen, M | 1 |
| Tessarin, G | 1 |
| Vogl, TJ | 1 |
| Schoepf, UJ | 2 |
| De Cecco, CN | 1 |
| Mu, R | 1 |
| Meng, Z | 1 |
| Zhang, X | 1 |
| Guo, Z | 1 |
| Zheng, W | 1 |
| Zhuang, Z | 1 |
| Zhu, X | 1 |
| Andersen, MB | 1 |
| Drljevic-Nielsen, A | 1 |
| Thygesen, J | 1 |
| Kruis, MF | 1 |
| Hjorthaug, K | 1 |
| Rasmussen, F | 1 |
| Nijkamp, JA | 1 |
| Tian, S | 1 |
| Jianguo, X | 1 |
| Tian, W | 1 |
| Li, Y | 1 |
| Hu, J | 1 |
| Wang, M | 1 |
| Zhang, J | 1 |
| Zhang, Z | 1 |
| Zou, H | 1 |
| Yuan, A | 1 |
| Jiang, F | 1 |
| Zhao, B | 1 |
| Liu, Y | 1 |
| Chen, J | 1 |
| Zuo, M | 1 |
| Gong, L | 1 |
| Lin, L | 1 |
| Cheng, J | 1 |
| Tang, D | 1 |
| Zhang, Y | 1 |
| Zhang, F | 1 |
| Xu, J | 1 |
| Jiang, H | 1 |
| Wu, H | 1 |
| Baxa, J | 4 |
| Ludvik, J | 2 |
| Sedlmair, M | 4 |
| Flohr, T | 4 |
| Schmidt, B | 4 |
| Hošek, P | 1 |
| Pesek, M | 2 |
| Svatoň, M | 1 |
| Ferda, J | 4 |
| Tanaka, M | 1 |
| Koji, I | 1 |
| Fujioka, I | 1 |
| Sato, M | 1 |
| Hirose, K | 1 |
| Kawaguchi, H | 1 |
| Hatayama, Y | 1 |
| Takai, Y | 1 |
| Tsushima, E | 1 |
| Aoki, M | 1 |
| Matouskova, T | 3 |
| Bejcek, J | 2 |
| Xu, X | 1 |
| Sui, X | 1 |
| Zhong, W | 1 |
| Xu, Y | 1 |
| Wang, Z | 1 |
| Jiang, J | 1 |
| Ge, Y | 1 |
| Song, L | 1 |
| Du, Q | 1 |
| Wang, X | 2 |
| Song, W | 1 |
| Jin, Z | 1 |
| Vondráková, A | 1 |
| Růžičková, O | 1 |
| Krakorova, G | 1 |
| Li, X | 1 |
| Meng, X | 1 |
| Ye, Z | 1 |
| Yang, F | 1 |
| Dong, J | 1 |
| Fu, X | 1 |
| Zhang, T | 1 |
| Schmid-Bindert, G | 1 |
| Henzler, T | 1 |
| Chu, TQ | 1 |
| Meyer, M | 1 |
| Nance, JW | 1 |
| Dinter, DJ | 1 |
| Apfaltrer, P | 1 |
| Krissak, R | 1 |
| Manegold, C | 1 |
| Schoenberg, SO | 1 |
| Fink, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: Prospective Multicenter-Multinational Trial in Patients Undergoing Targeted Therapy With a TKI Inhibitor.[NCT03404076] | 93 participants (Actual) | Observational | 2014-12-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 other studies available for iodine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Therapy response assessment of non-small cell lung cancer using dual-energy computed tomography iodine map.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Contrast Media; Humans; Iodine; Lung Neoplasms; T | 2022 |
Tumorous tissue characterization using integrated 18F-FDG PET/dual-energy CT in lung cancer: Combining iodine enhancement and glycolytic activity.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Neoplasm Sta | 2022 |
Parameters of Dual-layer Spectral Detector CT Could be Used to Differentiate Non-Small Cell Lung Cancer from Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Iodine; Lung Neoplasms; Retrospective Studies; Tomography, X | 2022 |
Assessment of Correlation between Dual-Energy Ct (De-Ct)-Derived Iodine Concentration and Local Flourodeoxyglucose (Fdg) Uptake in Patients with Primary Non-Small-Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Positron Emi | 2022 |
Application of dual-energy computed tomography in preoperative evaluation of Ki-67 expression levels in solid non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Humans; Iodine; Ki-67 Antigen; Lung Neoplas | 2022 |
A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Contrast Media; Diag | 2020 |
The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC.
Topics: Aged; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; ErbB Receptors; Fem | 2020 |
Correlation of Iodine Quantification and FDG Uptake in Early Therapy Response Assessment of Non-small Cell Lung Cancer: Possible Benefit of Dual-energy CT Scan as an Integral Part of PET/CT Examination.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Huma | 2020 |
Impact of low iodine density tumor area ratio on the local control of non-small cell lung cancer through stereotactic body radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cardiac Output; Female; Humans; Iodine; Lun | 2021 |
Single-source Dual-energy CT as a Part of
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Ne | 2018 |
Clinical utility of quantitative dual-energy CT iodine maps and CT morphological features in distinguishing small-cell from non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Different | 2019 |
Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Humans; Iodine; Lung Neoplasms; | 2014 |
Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Humans | 2016 |
Iodine quantification to characterize primary lesions, metastatic and non-metastatic lymph nodes in lung cancers by dual energy computed tomography: An initial experience.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Ioh | 2016 |
Non-small cell lung cancer: Spectral computed tomography quantitative parameters for preoperative diagnosis of metastatic lymph nodes.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Humans; Iodine; Lung Neoplasms; | 2017 |
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Huma | 2012 |